Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.82%) $83.16
Gas
(-1.16%) $1.619
Gold
(-0.43%) $2 337.20
Silver
(0.91%) $27.50
Platinum
(0.57%) $927.40
USD/EUR
(-0.17%) $0.933
USD/NOK
(-0.17%) $11.01
USD/GBP
(-0.26%) $0.798
USD/RUB
(0.00%) $92.17

Realaus laiko atnaujinimai Mangalam Drugs & Organics [MANGALAM.NS]

Birža: NSE Sektorius: Healthcare Pramonė: Drug Manufacturers—Specialty & Generic
Atnaujinta26 bal. 2024 @ 12:59
25% discount on Stockinvest.us - Use code: Podcast

-0.05% INR 100.70

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 12:59):

Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications...

Stats
Šios dienos apimtis 20 220.00
Vidutinė apimtis 133 715
Rinkos kapitalizacija 1.59B
EPS INR0 ( 2024-02-13 )
Last Dividend INR0.500 ( 2017-12-21 )
Next Dividend INR0 ( N/A )
P/E -14.06
ATR14 INR0.198 (0.20%)

Tūris Koreliacija

Ilgas: -0.27 (neutral)
Trumpas: 0.59 (weak)
Signal:(47.234) Neutral

Mangalam Drugs & Organics Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Mangalam Drugs & Organics Koreliacija - Valiuta/Žaliavos

The country flag -0.01
( neutral )
The country flag -0.30
( neutral )
The country flag 0.00
( neutral )
The country flag 0.43
( neutral )
The country flag 0.28
( neutral )
The country flag -0.55
( weak negative )

Mangalam Drugs & Organics Finansinės ataskaitos

Annual 2022
Pajamos: INR3.70B
Bruto pelnas: INR1.20B (32.29 %)
EPS: INR0.800
FY 2022
Pajamos: INR3.70B
Bruto pelnas: INR1.20B (32.29 %)
EPS: INR0.800
FY 2022
Pajamos: INR4.47B
Bruto pelnas: INR1.36B (30.44 %)
EPS: INR12.42
FY 2021
Pajamos: INR3.80B
Bruto pelnas: INR1.24B (32.66 %)
EPS: INR17.67

Financial Reports:

No articles found.

Mangalam Drugs & Organics Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A)

Mangalam Drugs & Organics Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 2.16 - No dividend growth expected in the near future
Information
First Dividend INR0.200 2005-08-30
Last Dividend INR0.500 2017-12-21
Next Dividend INR0 N/A
Payout Date 2017-12-29
Next Payout Date N/A
# dividends 4 --
Total Paid Out INR2.90 --
Avg. Dividend % Per Year 0.00% --
Score 0.48 --
Div. Sustainability Score 0
Div.Growth Potential Score 2.16
Div. Directional Score 0.784 --
Next Divdend (Est)
 (2024-09-26)
INR0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
0.48
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2005 INR0 0.00%
2006 INR0 0.00%
2007 INR0 0.00%
2008 INR0 0.00%
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR0 0.00%
2019 INR0 0.00%
2020 INR0 0.00%
2021 INR0 0.00%
2022 INR0 0.00%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SARDAEN.NS Dividend Junior 2023-09-07 Annually 15 0.65%
MAGADSUGAR.NS Dividend Junior 2023-07-13 Annually 7 1.78%
GMDCLTD.NS Dividend Knight 2023-09-22 Annually 23 3.41%
ASTRAMICRO.NS Dividend Junior 2023-08-23 Annually 20 0.49%
TITAN.NS Dividend Junior 2023-07-13 Annually 20 0.35%
PETRONET.NS Dividend Knight 2023-08-18 Semi-Annually 18 2.36%
JASH.NS Dividend Junior 2023-09-22 Annually 7 0.57%
DBOL.NS Dividend Junior 2023-06-23 Insufficient data to determine frequency 2 0.56%
SILINV.NS Dividend Junior 2023-08-18 Annually 23 0.63%
MBAPL.NS Dividend Junior 2023-09-18 Annually 8 0.44%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.04731.500-0.945-1.418[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM-0.1191.500-2.44-3.66[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM-0.5411.000-1.312-1.312[3 - 30]
operatingCashFlowPerShareTTM17.102.004.308.60[0 - 30]
freeCashFlowPerShareTTM17.102.001.4482.90[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.2861.0008.578.57[0.2 - 0.8]
operatingProfitMarginTTM-0.02021.000-2.40-2.40[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score-0.593

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-9.381.000-1.0490[1 - 100]
returnOnEquityTTM-0.1192.50-1.568-3.66[0.1 - 1.5]
freeCashFlowPerShareTTM17.102.004.302.90[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM17.102.004.308.60[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.8801.5007.470[0.5 - 2]
operatingCashFlowSalesRatioTTM0.07531.000-0.6170[0.1 - 0.5]
Total Score2.16

Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.